Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea-Reference-Cited by-同舟云学术

Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea

Published:2017-01-15 Issue:1 Volume:49 Page:193-203
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Kim Byung Sup,Seol Ho Jun,Nam Do-Hyun,Park Chul-Kee,Kim Il Han,Kim Tae Min,Kim Jeong Hoon,Cho Young Hyun,Yoon Sang Min,Chang Jong Hee,Kang Seok-Gu,Kim Eui Hyun,Suh Chang-Ok,Jung Tae-Young,Lee Kyung-Hwa,Kim Chae-Yong,Kim In Ah,Hong Chang-Ki,Yoo Heon,Kim Jin Hee,Kang Shin-Hyuk,Kang Min Kyu,Kim Eun-Young,Kim Sun-Hwan,Chung Dong-Sup,Hwang Sun-Chul,Song Joon-Ho,Cho Sung Jin,Lee Sun-Il,Lee Youn-Soo,Ahn Kook-Jin,Kim Se Hoon,Lim Do Hun,Gwak Ho-Shin,Lee Se-Hoon,Hong Yong-Kil

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://e-crt.org/upload/pdf/crt-2015-473.pdf

Reference25 articles.

1. Higher pAkt Expression Predicts a Significant Worse Prognosis in Glioblastomas

2. Brain Tumors

3. Factors influencing survival in high-grade gliomas

4. Recursive Partitioning Analysis of Prognostic Factors in Three Radiation Therapy Oncology Group Malignant Glioma Trials

5. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NTRK-fused central nervous system tumours: clinicopathological and genetic insights and response to TRK inhibitors;Acta Neuropathologica Communications;2024-07-16

2. Letter to the Editor Regarding Cerebral Blood Flow Role in Delineating Treatment Effect from True Tumor Progression in Glioblastoma Multiforme;World Neurosurgery;2024-06

3. Glioma angiogenesis is boosted by ELK3 activating the HIF-1$$\alpha$$/VEGF-A signaling axis;BMC Cancer;2023-07-14

4. Lymphoproliferative disorder during temozolomide therapy; a representative case of a formidable complication and management challenges;BMC Neurology;2023-06-09

5. Lymphoproliferative disorder during temozolomide therapy; a representative case of a formidable complication and management challenges;2023-03-07